Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Viral Immunol ; 30(10): 682-690, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-29028178

RESUMO

The sudden emergence of infectious pathogens such as Zika virus (ZIKV) holds global health concerns. Recent dissemination of ZIKV from Pacific to Americas with an upsurge of congenital anomalies and Guillain Barre Syndrome (GBS) in adults has created an alarming situation. High-throughput studies are in progress to understand ZIKV's mode of pathogenesis and mechanism of immune escape, yet the pathogenesis remains obscure. Mainly ZIKV's envelope (E) protein and nonstructural proteins (mainly NS1 and NS5) manipulate host cell to support viral immune escape by modulation of the interferon pathway and complement antagonism. The development of direct therapeutics for ZIKV infection is required to overcome the rapidly evolving viral threat. Currently, the existing strategies for ZIKV treatment are only supportive. Although, there is no prophylactic or therapeutic vaccine presently available, however, recent efforts have brought up ZIKV vaccines into clinical trial phase 1. This review presents the highlights of recent advances in understanding immune evasion strategies adapted by ZIKV and existing therapies against the virus.


Assuntos
Interações Hospedeiro-Patógeno/imunologia , Evasão da Resposta Imune , Vacinas Virais/imunologia , Infecção por Zika virus/imunologia , Infecção por Zika virus/terapia , Zika virus/imunologia , Humanos , Modelos Biológicos , Proteínas Virais/imunologia , Vacinas Virais/isolamento & purificação , Zika virus/genética , Zika virus/patogenicidade , Infecção por Zika virus/prevenção & controle , Infecção por Zika virus/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...